We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04256473
Brief Title: Dual Thrombolytic Therapy With Mutant Pro-urokinase and Low Dose Alteplase for Ischemic Stroke (DUMAS)

First Submitted : February 3, 2020
First Submitted that Met QC Criteria : February 4, 2020
First Posted : February 5, 2020

Last Update Submitted that Met QC Criteria : June 17, 2021
Last Update Posted : June 18, 2021